[CHICAGO] Jan. 5 2026—XOMD Skincare, the first clinically proven "Moodceutical", designed to elevate both skin quality and emotional well-being, is officially expanding into Europe and beyond through strategic distribution with EvoMD Sp. z o.o.
Coined for its ability to improve the appearance of skin through ameliorating the user's mood, XOMD Skincare is inspired by oxytocin, "the love hormone", for that fresh-faced glow worn by lovers.
This partnership marks XOMD’s largest global rollout to date, bringing the full collection, including the Detox Cleanser, Intoxicate Serum and Arouse Moisturizer, to 53 markets across Europe.
Moodceuticals' European Debut
Co-created by world-renowned aesthetic physicians Dr. Sabrina Fabi and Dr. Steven Dayan, XOMD explores the intersection of dermatology, neuroscience and their effects on emotional well-being.
While XOMD does not contain oxytocin, the formulas are designed to mimic oxytocin-associated pathways, which are tied to bonding, confidence, calm and connection.
In a rigorous, randomized, double-blind, placebo-controlled clinical trial, XOMD demonstrated improvements not only in skin brightness, smoothness and tone, but also in self-esteem, attractiveness perception, social confidence and intimacy metrics—representing an entirely new category in aesthetics.
“After meeting Sabrina and Steven, I instantly connected with the concept behind XOMD and the people who created it,” says Aistis Vasiliauskas, founder of EvoMD. “In my years in the aesthetic field, I have seen many brands come and go, but nothing has ever felt as original, as human or as scientifically aligned with the future of aesthetics as XOMD. Partnering with XOMD was an obvious choice for us.”
When it comes to introducing this new frontier of care to Europe, it couldn't come at a better time.
“The European aesthetic community has always been at the forefront of adopting ideas that reshape our understanding of beauty,” details Dr. Fabi. “Sharing the concept and access to Moodceuticals with the EU is especially meaningful because this region embraces innovation that is grounded in both science and humanity. With XOMD, we’re offering a new dimension of care.”
Dr. Dayan adds: “Our research has shown that the way people perceive themselves is influenced by far more than symmetry or surface-level changes. This expansion represents an evolution in aesthetic medicine, one where we acknowledge that emotional well-being is a vital part of the beauty equation. Through the XOMD LIFE partnership, we’re able to share a new approach to skin care with millions across Europe, inviting them to experience neurocosmetic products designed to elevate mood, confidence and the way they navigate the world.”
EU Availability
XOMD products are now available for sale throughout the EU, and consumers may purchase directly through xomd.life, which ships to all 53 markets. Clinics, medical aesthetic practices and authorized retailers may contact EvoMD Sp. z o.o. directly to place orders.
